Odyssey Thera's Series C Round

Odyssey Thera raised a round of funding on March 06, 2010.

Odyssey Thera offers technology that measures disease-relevant pathway activity within living human cells. Rapid identification of on-target and off-pathway activities of lead compounds enables select…

Articles about Odyssey Thera's Series C Round: